RXRX News and Press, Recursion Pharmaceuticals Inc. From 01/03/24

2024-01-03 11:15:00 ET Cathie Wood kicked off the new trading year with three fresh purchases for her Ark Invest family of exchange-traded funds. All three stocks coincidentally begin with the letter "R" -- even though it wasn't a pirate-themed shopping spree. ( Arrr , anyone?) ...

SALT LAKE CITY, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that Chris Gibson, Ph.D., Co-founder and CEO, will help kick off the 42nd Annual J.P. Morgan Healthcare Confer...

2023-12-26 13:19:21 ET More on AbCellera Biologics, Absci, etc. Exscientia Looks Promising In AI-Driven Drug Development AbCellera: Difficult 2023 Suggests Business Model Should Pivot In 2024 Buy AbCellera Biologics's Revolutionizing AI-Powered Drug Development Platf...

2023-12-25 05:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-22 17:56:28 ET Summary The biotech bear market has presented investment opportunities for investors to take meaningful stakes in public companies at venture valuations. AI drug discovery has faced setbacks in the past 18 months, but Gain Therapeutics' has found success usi...

KYIV, Ukraine and SALT LAKE CITY, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its partnership with Enamine, a world-renowned provider of novel molecules and contract research...

2023-12-16 13:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the biggest stories of the year has been the rise of AI in every industry. This trend will hit biotech stocks no less than any others. Already, cutting edge healthcare stocks ...

2023-12-10 13:04:00 ET More on AbCellera Biologics, Absci, etc. AbCellera: Difficult 2023 Suggests Business Model Should Pivot In 2024 Buy AbCellera Biologics's Revolutionizing AI-Powered Drug Development Platform Certara, Inc. 2023 Q3 - Results - Earnings Call Prese...

2023-11-26 09:30:00 ET For a biotech like Recursion Pharmaceuticals (NASDAQ: RXRX) that aims to use artificial intelligence (AI) and petabytes of data as tools for drug discovery and development, computing power is a key resource. Without a lot of computational capacity, there's sim...

2023-11-22 23:31:20 ET Summary ARK Genomic Revolution ETF focuses on genomic innovation in sectors such as healthcare, information technology, and energy. The fund's buying and selling activity gives us clues about the degrees of conviction relative to its main holdings. The f...